• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:陈慧敏,赵建波,邱相君,吴明伍,陈汇.HPLC检测人血浆中厄贝沙坦的浓度[J].中国现代应用药学,2010,27(5):422-425.
.Determination of Irbesartan in Human Plasma by HPLC[J].Chin J Mod Appl Pharm(中国现代应用药学),2010,27(5):422-425.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2021次   下载 1792 本文二维码信息
码上扫一扫!
分享到: 微信 更多
HPLC检测人血浆中厄贝沙坦的浓度
陈慧敏,赵建波,邱相君,吴明伍,陈汇
作者单位
摘要:
目的 建立人血浆厄贝沙坦检测的高效液相色谱法。方法 血浆经乙醚萃取,以ZORBAX Extend-C18为色谱柱;流动相为乙腈-水-0.1%TFA-0.5 mmol·L-1 SDS体系,流速为0.8 mL·min-1;检测波长为242 nm(0~6.5 min)和266 nm(6.5~7.8 min)。结果 厄贝沙坦浓度在0.05~6.00 mg·L-1内线性关系良好(r=0.999 9);定量限为0.05 mg·L-1;高中低3个浓度的相对回收率分别为(103.93±1.09)%、(99.85±0.65)%和(100.95±1.21)%;日内RSD分别为3.04%,1.15%,1.19%,日间RSD分别为4.50%,3.32%,1.18%。结论 本方法准确可靠、简便快速,适用于人血浆厄贝沙坦浓度的测定及其药动学研究。
关键词:  高效液相色谱法  厄贝沙坦  血药浓度  药动学
DOI:
分类号:
基金项目:
Determination of Irbesartan in Human Plasma by HPLC
CHEN Huimin1  ZHAO Jianbo2  QIU Xiangjun3  WU Mingwu3  CHEN Hui4
Abstract:
OBJECTIVE To develop a high performance liquid chromatography method for the determination of irbesartan in human plasma. METHODS The plasma were extracted by diethyl ether. The analytical column was packed with ZORBAX Extend-C18. The mobile phase were acetonitrile-water-0.1% trifluoroacetic acid-0.5 mmol·L-1 SDS and the flow rate was 0.8 mL·min-1. The UV detection wavelength was 242 nm(0-6.5min) and 266 nm(6.5-7.8min). RESULTS Excellent liner relationship was obtained in the range of 0.05-6.00 mg·L-1(r=0.999 9). The limit determination of irbesartan was 0.05 mg·L-1. The relative recoveries were (103.93±1.09)%, (99.85±0.65)% and(100.95±1.21)% respectively at three concentrations, the intra-day RSD were 3.04%, 1.15% and 1.19% and inter-day RSD were 4.50%, 3.32% and 1.18%, respectively. CONCLUSION The method was accurate, simple, rapid and could be used to determine the irbesartan concentration in human plasma and for study of its pharmacokinetics.
Key words:  HPLC  irbesartan  plasma concentration  pharmacokinetics
扫一扫关注本刊微信